Balanced news tone
News Sentiment
HAE sentiment intelligence
Haemonetics Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
78/100 classification confidence.
directly relevant articles
high-authority source matches
+1.5% over one week, -2.6% over four weeks, trend inactive, and near fair-value range.
Haemonetics Price Target Raised to $90.00/Share From $85.00 by Mizuho
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
HAE Forecast — Price Target — Prediction for 2027
This article provides a forecast for Haemonetics Corporation (HAE) stock, including analyst price targets, current stock performance, and financial data. It covers historical prices, volatility, market capitalization, upcoming earnings reports, and revenue details, while also add
- Tone
- Positive 64/100
- Event
- Earnings
- Published
- 25 Jun 2026 23:40
- Source
- TradingView
Haemonetics Jumps 5.9% Amid Sector-Wide Rally
Haemonetics Corporation (HAE) saw its stock surge by 5.9% on Thursday, closing at $77.16 due to a broad sector-wide rally, not company-specific news. The strong performance, which included sector peers like QDEL and NEOG also making gains, suggests a general investor rotation int
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 25 Jun 2026 19:39
- Source
- AlphaStreet
Haemonetics Corp (HAE) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Haemonetics Corp (HAE), focusing on its price momentum, support and resistance levels, and various technical indicators and moving averages. As of June 18, 2026, HAE has a price momentum score of 9.04, trading between a resistance of
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 20:40
- Source
- TradingKey
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jun 2026 07:00
- Source
- StockStory
A Look At Haemonetics (HAE) Valuation After Its New Apheresis And MedSurg Segment Realignment
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- Market source
HAEMONETICS CORP ($HAE) President and CEO 2026 Pay Revealed
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- Quiver Quantitative
Is Haemonetics (HAE) Stock Price Reflecting Its Recent 29% Monthly Surge Accurately
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 07 Jun 2026 07:00
- Source
- simplywall.st
Haemonetics Narrows Reporting Structure
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 11:04
- Source
- MT Newswires
Haemonetics (NYSE: HAE) consolidates business into new Apheresis and MedSurg segments
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Stock Titan
Haemonetics' (NYSE:HAE) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 May 2026 07:00
- Source
- simplywall.st
Why Haemonetics (HAE) Is Up 14.3% After Earnings Beat And BofA Upgrade And What's Next
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 25 May 2026 07:00
- Source
- Market source
Haemonetics (HAE) Stock Is Up, What You Need To Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 May 2026 07:00
- Source
- Market source
Haemonetics upgraded at BofA on conservative outlook
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 22 May 2026 07:00
- Source
- Seeking Alpha
Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- Market source
Does Haemonetics (HAE) Have Enduring Growth Potential?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- Market source
Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 May 2026 07:00
- Source
- Market source
A Look At Haemonetics (HAE) Valuation After Recent Share Price Weakness
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 07:00
- Source
- Market source
Haemonetics (HAE) One Off Loss And Margin Hit Challenge Bullish Earnings Narrative
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 May 2026 07:00
- Source
- simplywall.st
Haemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- Market source
Haemonetics (NYSE:HAE) Reports Upbeat Q1 CY2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 May 2026 07:00
- Source
- StockStory
Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to Say
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- Market source
Haemonetics to Present at Bank of America 2026 Healthcare Conference
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- PR Newswire
Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Apr 2026 07:00
- Source
- Market source
Mizuho Adjusts Haemonetics Corporation (HAE) Estimates in Sector-Wide Review
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Apr 2026 07:00
- Source
- Market source
A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Apr 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Apr 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Mar 2026 07:00
- Source
- Market source
Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Mar 2026 07:00
- Source
- StockStory
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Mar 2026 07:00
- Source
- Market source
Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Mar 2026 07:00
- Source
- Market source